We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,402
Reduced
945
Closed
112
Avg Time Held
25.8
quarters
Top 10 Avg Time Held
18.2
quarters
Top 20 Avg Time Held
19.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PRHI
4451
Presurance Holdings
PRHI
$31.1M
| $47.7K | ﹤0.01% |
4,343
| – | – |
2015 Q4
28 quarters
|
|
|
PTPI
4452
DELISTED
Petros Pharmaceuticals
PTPI
| $46.1K | ﹤0.01% |
792
-232
| -23% | -$22.4K |
2020 Q4
8 quarters
|
|
4453
BK Technologies
BKTI
$279M
| $45.8K | ﹤0.01% |
2,761
+55
| +2% | +$716 |
2022 Q3
1 quarter
|
|
|
DMRA
4454
Damora Therapeutics
DMRA
$1.34B
| $45.5K | ﹤0.01% |
1,583
+214
| +16% | +$8.88K |
2021 Q2
6 quarters
|
|
4455
Xenetic Biosciences
XBIO
$5.04M
| $45.2K | ﹤0.01% |
15,862
-45,785
| -74% | -$202K |
2020 Q4
8 quarters
|
|
|
WORX
4456
DELISTED
SCWORX CORP NEW
WORX
| $43.4K | ﹤0.01% |
488
+1
| +0.2% | +$127 |
2019 Q4
12 quarters
|
|
|
GHSI
4457
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $41.8K | ﹤0.01% |
5,766
| – | – |
2019 Q4
12 quarters
|
|
|
FRTX
4458
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $41.7K | ﹤0.01% |
27,779
| – | – |
2013 Q2
38 quarters
|
|
|
DYNT
4459
DELISTED
Dynatronics Corp
DYNT
| $41.5K | ﹤0.01% |
21,288
+50
| +0.2% | +$113 |
2018 Q3
17 quarters
|
|
|
NMAD
4460
Nomad Power Solutions
NMAD
$74.1M
| $41.3K | ﹤0.01% |
8,113
| – | – |
2021 Q2
6 quarters
|
|
|
CFRX
4461
DELISTED
ContraFect Corporation
CFRX
| $40.7K | ﹤0.01% |
5,300
-2,569
| -33% | -$29.7K |
2015 Q1
31 quarters
|
|
|
IDW
4462
DELISTED
IDW Media Holdings
IDW
| $40.3K | ﹤0.01% |
42,882
| – | – |
2022 Q1
3 quarters
|
|
4463
Exicure
XCUR
$7.14M
| $40K | ﹤0.01% |
6,964
| – | – |
2019 Q3
13 quarters
|
|
|
NVIV
4464
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $39.8K | ﹤0.01% |
16,946
| – | – |
2022 Q3
1 quarter
|
|
|
HMPT
4465
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $38.3K | ﹤0.01% |
27,960
-1,464
| -5% | -$2.26K |
2021 Q1
7 quarters
|
|
|
BSFC
4466
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
| $35.7K | ﹤0.01% |
89
| – | – |
2022 Q1
3 quarters
|
|
|
NVOS
4467
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
| $35.2K | ﹤0.01% |
17,483
-8,111
| -32% | -$27.9K |
2021 Q2
6 quarters
|
|
|
DWTX
4468
Dogwood Therapeutics
DWTX
$47.9M
| $35.1K | ﹤0.01% |
5,946
-3,721
| -38% | -$28K |
2021 Q2
6 quarters
|
|
4469
T Stamp
IDAI
$19.1M
| $34.9K | ﹤0.01% |
967
+9
| +0.9% | +$523 |
2022 Q2
2 quarters
|
|
|
RHE
4470
DELISTED
Regional Health Properties, Inc.
RHE
| $34.9K | ﹤0.01% |
10,499
+45
| +0.4% | +$119 |
2022 Q3
1 quarter
|
|
|
MDRR
4471
Medalist Diversified Inc
MDRR
$17.1M
| $34.8K | ﹤0.01% |
3,110
+55
| +2% | +$676 |
2022 Q2
2 quarters
|
|
|
ASAP
4472
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $33.6K | ﹤0.01% |
96,663
-96,657
| -50% | -$180K |
2018 Q4
16 quarters
|
|
4473
Journey Medical
DERM
$182M
| $32.5K | ﹤0.01% |
16,949
+106
| +0.6% | +$210 |
2022 Q2
2 quarters
|
|
|
STAB
4474
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $30.7K | ﹤0.01% |
378,677
| – | – |
2013 Q2
38 quarters
|
|
|
BLNE
4475
Beeline Holdings
BLNE
$23.5M
| $30.4K | ﹤0.01% |
665
-69
| -9% | -$3.88K |
2018 Q1
19 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.